Pharmagreen Biotech Stock Market Value
| PHBI Stock | USD 0 0.0001 5.88% |
| Symbol | Pharmagreen |
Pharmagreen Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pharmagreen Biotech's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pharmagreen Biotech.
| 06/02/2024 |
| 11/29/2024 |
If you would invest 0.00 in Pharmagreen Biotech on June 2, 2024 and sell it all today you would earn a total of 0.00 from holding Pharmagreen Biotech or generate 0.0% return on investment in Pharmagreen Biotech over 180 days. Pharmagreen Biotech Inc., a biotech sciences solutions company, focuses on the production of starter plantlets for CBD h... More
Pharmagreen Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pharmagreen Biotech's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pharmagreen Biotech upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 12.82 | |||
| Information Ratio | 0.1201 | |||
| Maximum Drawdown | 63.53 | |||
| Value At Risk | (16.00) | |||
| Potential Upside | 27.27 |
Pharmagreen Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharmagreen Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pharmagreen Biotech's standard deviation. In reality, there are many statistical measures that can use Pharmagreen Biotech historical prices to predict the future Pharmagreen Biotech's volatility.| Risk Adjusted Performance | 0.1085 | |||
| Jensen Alpha | 1.89 | |||
| Total Risk Alpha | (0.30) | |||
| Sortino Ratio | 0.1283 | |||
| Treynor Ratio | (1.51) |
Pharmagreen Biotech Backtested Returns
Pharmagreen Biotech is out of control given 3 months investment horizon. Pharmagreen Biotech maintains Sharpe Ratio (i.e., Efficiency) of 0.13, which implies the firm had a 0.13% return per unit of risk over the last 3 months. We have analyzed thirty different technical indicators, which can help you to evaluate if expected returns of 1.84% are justified by taking the suggested risk. Use Pharmagreen Biotech Semi Deviation of 10.38, coefficient of variation of 773.46, and Risk Adjusted Performance of 0.1085 to evaluate company specific risk that cannot be diversified away. Pharmagreen Biotech holds a performance score of 10 on a scale of zero to a hundred. The company holds a Beta of -1.17, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Pharmagreen Biotech are expected to decrease by larger amounts. On the other hand, during market turmoil, Pharmagreen Biotech is expected to outperform it. Use Pharmagreen Biotech potential upside, rate of daily change, and the relationship between the sortino ratio and skewness , to analyze future returns on Pharmagreen Biotech.
Auto-correlation | 0.13 |
Insignificant predictability
Pharmagreen Biotech has insignificant predictability. Overlapping area represents the amount of predictability between Pharmagreen Biotech time series from 2nd of June 2024 to 31st of August 2024 and 31st of August 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pharmagreen Biotech price movement. The serial correlation of 0.13 indicates that less than 13.0% of current Pharmagreen Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.13 | |
| Spearman Rank Test | -0.09 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Pharmagreen Biotech lagged returns against current returns
Autocorrelation, which is Pharmagreen Biotech pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pharmagreen Biotech's pink sheet expected returns. We can calculate the autocorrelation of Pharmagreen Biotech returns to help us make a trade decision. For example, suppose you find that Pharmagreen Biotech has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Pharmagreen Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pharmagreen Biotech pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pharmagreen Biotech pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pharmagreen Biotech pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Pharmagreen Biotech Lagged Returns
When evaluating Pharmagreen Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pharmagreen Biotech pink sheet have on its future price. Pharmagreen Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pharmagreen Biotech autocorrelation shows the relationship between Pharmagreen Biotech pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Pharmagreen Biotech.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Pharmagreen Pink Sheet
Pharmagreen Biotech financial ratios help investors to determine whether Pharmagreen Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmagreen with respect to the benefits of owning Pharmagreen Biotech security.